-
Bharti Airtel
1,956.00 2,174.70(%) -
Bluestone Jewel
872.60 872.60(%) -
Anthem Bioscienc
735.10 579.45(%) -
IndusInd Bank
1,077.80 1,077.80(%) -
M & M Fin. Serv.
384.55 412.30(%) -
Data Pattern
4,800.00 4,955.00(%) -
TVS Motor Co.
3,965.00 3,970.00(%) -
Cummins India
5,635.00 6,142.80(%) -
Bajaj Auto
11,025.00 11,025.00(%) -
SBI Funds Mgt.
582.55 582.55(%) -
Bandhan Bank
169.65 134.30(%) -
HDFC Bank
750.25 726.75(%) -
Kalyan Jewellers
601.25 617.30(%) -
Eternal
275.70 212.55(%) -
Reliance Industries
1,284.00 1,253.65(%) -
Bajaj Finance
1,056.30 788.40(%) -
Dixon Technolog.
13,650.00 9,605.05(%) -
Himadri Special
760.20 420.00(%) -
Titan Company
4,730.10 4,730.10(%) -
Nestle India
1,509.75 1,509.75(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Pfizer Ltd Pharmaceuticals - Multinational
- MNC Associate
- BSE Code : 434.0
- ISIN : INE182A01018
-
Today’s Low
4,531.20 -
Today’s High
4,684.30
-
Open
4,585.70 -
Perv Close
4,593.30 -
52W Low
4,360.10 -
52W High
5,873.50
Key Indicators
-
P/E(TTM)
27.99
-
Mar.Cap (₹Cr.)
21,247.99
-
Div & Yield %
1.62
-
Book Value(₹)
918.71
-
Debt-Equity Ratio
1.12
-
AGM Date
22-Jul-2026
-
EPS
165.84
-
P/E Ratio
27.99
Financials Ratios
-
Debt-Equity Ratio
-
-
Mar.Cap (₹Cr.)
21,247.99
-
RONW (%)
-
-
ROCE (%)
-
Score Board
-
Equity (₹ in Cr.)
45.75
-
BV (₹)
918.70
-
Sales( ₹ in Cr.)
2,519.65
-
NP (in Cr.)
758.68
-
NP Var(%)
37.0
-
Div%
750.0
-
CPS (₹)
178.50
-
EPS (₹)
165.80
-
Traded Value (₹ in Lakhs)
21,235.87
-
52 Week High
5,873.50
-
52 Week Low
4,360.10
-
Price BSE
4642.0
-
Price NSE
4,645.00
-
Market Capital( in Cr.)
21,235.87
-
P/C Ratio
26.00
-
P/E Ratio
28.00
-
Price Vs.BV
165.80
-
21-Jul-2026( 10:05)
Corporate News - Pfize... - Pfizer will hold a meeting of...
-
13-May-2026( 09:44)
Corporate News - Board... - Pfizer announced that the Boar...
-
13-May-2026( 09:44)
Corporate News - Pfize... - Pfizer announced that the 75th...
-
13-May-2026( 07:28)
Results - Announcements - Pfize... - Net profit of Pfizer declined...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 2,519.65 | 2,281.35 | 2,193.17 | 2,424.76 | 2,610.99 | 2,238.55 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 2,519.65 | 2,281.35 | 2,193.17 | 2,424.76 | 2,610.99 | 2,238.55 |
| Other Income | 187.95 | 345.06 | 188.46 | 134.05 | 62.65 | 81.12 |
| Stock Adjustments | 33.59 | -25.36 | 11.82 | -56.48 | 72.90 | -14.35 |
| Total Income | 2,741.19 | 2,601.05 | 2,393.45 | 2,502.33 | 2,746.54 | 2,305.32 |
| EXPENDITURE : | ||||||
| Raw Materials | 917.90 | 785.09 | 804.39 | 817.19 | 1,020.93 | 783.39 |
| Power and Fuel Cost | 3.20 | 3.48 | 3.98 | 6.51 | 5.67 | 5.79 |
| Employee Cost | 367.97 | 371.33 | 347.80 | 331.68 | 403.67 | 361.06 |
| Other Manufacturing Expenses | 58.01 | 50.54 | 51.17 | 51.63 | 59.81 | 60.26 |
| Selling and Administration Expenses | 259.96 | 260.05 | 317.96 | 298.03 | 310.77 | 268.67 |
| Miscellaneous Expenses | 91.18 | 45.18 | 44.37 | 54.29 | 47.10 | 32.63 |
| Employee Benefit Expenses | 367.97 | 371.33 | 347.80 | 331.68 | 403.67 | 361.06 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 1,698.22 | 1,515.67 | 1,569.67 | 1,559.33 | 1,847.95 | 1,511.80 |
| Operating Profit | 1,042.97 | 1,085.38 | 823.78 | 943.00 | 898.59 | 793.52 |
| Interest | 9.57 | 8.50 | 15.43 | 13.48 | 10.70 | 15.39 |
| Gross Profit | 1,033.40 | 1,076.88 | 808.35 | 929.52 | 887.89 | 778.13 |
| Depreciation | 57.73 | 60.79 | 62.28 | 105.51 | 115.00 | 109.41 |
| Profit Before Tax | 975.67 | 1,016.09 | 746.07 | 824.01 | 772.89 | 668.72 |
| Current Tax | 257.52 | 264.10 | 158.63 | 251.99 | 196.26 | 183.63 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -4.28 | -15.61 | 36.11 | -51.91 | -35.93 | -12.52 |
| Reported Net Profit | 722.43 | 767.60 | 551.33 | 623.93 | 612.56 | 497.61 |
| Extraordinary Items | -36.25 | 215.80 | 3.62 | 22.95 | 1.13 | 0.06 |
| Adjusted Net Profit | 758.68 | 551.80 | 547.71 | 600.98 | 611.43 | 497.55 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance brought forward | 2,435.86 | 1,828.39 | 1,460.05 | 1,133.47 | 681.03 | 1,693.08 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 754.84 | 160.13 | 182.99 | 297.35 | 160.12 | 1,509.66 |
| P & L Balance carried down | 2,403.45 | 2,435.86 | 1,828.39 | 1,460.05 | 1,133.47 | 681.03 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 750.00 | 1,650.00 | 350.00 | 400.00 | 350.00 | 350.00 |
| Dividend Per Share(Rs) | 75.00 | 165.00 | 35.00 | 40.00 | 35.00 | 35.00 |
| Earnings Per Share-Unit Curr | 157.91 | 167.78 | 120.51 | 136.38 | 133.89 | 108.77 |
| Earnings Per Share(Adj)-Unit Curr | 157.91 | 167.78 | 120.51 | 136.38 | 133.89 | 108.77 |
| Book Value | 918.67 | 921.84 | 785.91 | 701.05 | 626.10 | 523.07 |
| Book Value(Adj)-Unit Curr | 918.67 | 921.84 | 785.91 | 701.05 | 626.10 | 523.07 |
